An anti-idiotypic serum prepared against the combining site (idiotype) of specific anti-diphtheria toxoid antibodies was characterized with respect to its interaction with highly diphtheria toxin-sensitive Vero cells. Although the anti-idiotypic serum protected Vero cells against the cytotoxic action of diphtheria toxin, it did not prevent the binding of 125I-labeled diphtheria toxin to the cells but did inhibit the internalization and degradation of 125I-labeled toxin. This anti-idiotypic serum immunoprecipitated a cell-surface protein from radiolabeled Vero cells with an apparent Mr of 415,000.
125I-labeled diphtheria toxin to the cells but did inhibit the internalization and degradation of 125I-labeled toxin. This anti-idiotypic serum immunoprecipitated a cell-surface protein from radiolabeled Vero cells with an apparent Mr of 415,000.
These results are consistent with the hypothesis that the antiidiotypic serum contains antibodies that carry an internal image of an internalization site on the toxin and that a cellsurface protein involved in toxin internalization possesses a complementary site recognized by both the toxin and the anti-idiotypic antibodies.
Diphtheria toxin (DT) is a protein of Mr 58,342 synthesized as a single polypeptide chain that can be proteolytically cleaved to yield two distinct fragments, the amino-terminal A fragment (Mr 21, 167) and the carboxyl-terminal B fragment (Mr 37, 195) , which remain associated via a disulfide bond (1) (2) (3) (4) . The toxin possesses three functional domains: (i) the enzymatic domain, located in the A fragment, responsible for the NAD-dependent ADP-ribosylation of elongation factor 2 that results in inhibition of protein synthesis; (ii) the receptorbinding domain, located in the carboxyl-terminal region of the B fragment; and (iii) the internalization and entry domain, located in the middle of the B fragment (5, 6) . DT enters cells via receptor-mediated endocytosis (7, 8) by first binding to specific cell-surface receptors followed by internalization of (toxin-receptor) complexes into endosomes and entry of the A fragment into the cytosol where that fragment inhibits protein synthesis. Cell-surface DT-binding proteins from highly toxin-sensitive Vero cells have been reported with apparent Mr values of 15,000-20,000 and have been proposed as the DT receptor (9, 10) .
Anti-idiotypic antibodies raised against the binding sites (idiotypes) of antibodies to biologically important ligands have been used as cell-surface probes in such varied systems as the insulin receptor and retinol-binding protein receptor (11) , the /8-adrenergic receptor (12) , the membrane receptor for factor H (13), the thyrotropin receptor (14) , and a receptor for protein import into chloroplasts (15) . Observations (19) . Fig. 1 shows that preincubation of Vero cells with aId followed by DT treatment resulted in a 33-fold protective effect [i.e., the concentration of toxin that inhibits protein synthesis by 50% (IC50) was 1 x 10-5 mg/ml compared with an IC50 of 3 x 10-' mg/ml when toxin alone was used]. This protective effect was not seen with NpS (Fig.  1) , the hyperimmune anti-idiotypic serum incapable of inducing a DT-neutralizing anti-anti-idiotype.
Titration of aId with Radioiodinated DT. To ensure that the protective effect of aId was not from interaction of antibody with DT itself (22) , the serum was tested for its ability to immunoprecipitate radioiodinated DT; aId was unable to precipitate DT to any detectable extent, even when the ratio aId:DT was 40-fold greater than the lowest ratio found to be protective in the cytotoxicity experiments (Fig. 1) Effect of aId on the Internalization of DT. The fact that DT-mediated cytotoxicity was decreased in the presence of aId, although this same serum could not inhibit the binding of radiolabeled DT to intact cells suggested that aId may affect a step subsequent to toxin binding. Therefore, the kinetics of toxin internalization in the presence of aId were examined. Preliminary experiments indicated that coincubation of aId with radiolabeled DT, under conditions known to allow toxin internalization and degradation (20, 21) caused most DT to remain cell associated. To determine whether the cell-associated DT, in the presence of aId, remains surfacebound or resides in internal compartments, the fate of radiolabeled DT was followed and was compared with the fate of the toxin in the presence of NpS as described. Fig. 2 shows that after 3 hr at 37°C in the presence of NpS, most radiolabeled DT bound at to was rapidly internalized, degraded, and returned to the medium as trichloroacetic acidsoluble fragments (Fig. 2A) . In contrast, when radiolabeled DT was bound in the presence of aId, the majority of DT remained cell-surface bound, and the percentage of DT degraded after internalization was greatly reduced (Fig. 2B) . This result suggests that aId protects Vero cells by interacting with a cell-surface component, affecting a step in the intoxication process subsequent to DT binding.
Immunoprecipitation quently, '251-labeled DT (100 ng/ml) in the presence or absence of a 200-fold excess of unlabeled DT was added, and the incubation was continued for 4 hr at 4°C. Cell monolayers were washed and further incubated at 37°C. At the indicated times, radioactivity was separated into four fractions as described, corrected for nonspecific binding, and graphed as the percent of the total at each time. Total radioactivity represents the following fractions: surface-associated DT released by Pronase/InsP6 treatment (o, *); cell-associated DT-that is, intracellular DT plus that amount of surface-bound DT not released by Pronase/InsP6 (n, *); acid-soluble, degraded DT in the medium (A, A); and acid-precipitable DT in.the medium (v, v (Fig. 3B, lanes 2 and 3) . The rather a site involved in internalization, possibly located in the middle of the B fragment (6) .
The existence of a second cell-surface site involved in DT intoxication has previously been suggested. (i) Our laboratory (23) , based on biochemical experiments with solubilized DT-binding cell-surface proteins, suggested the existence of such a site on the receptor (X' site) that interacts with a site on the toxin (X site) distinct from the receptor-binding site and postulated that the X' site is involved in a step subsequent to the initial toxin binding. (ii) Didsbury et al. (24) suggested the existence of a second function for the receptor, or a second site, based on a distinct class of DT-resistant Chinese hamster ovary cells (Dipr) that bind toxin normally but are 10,000-fold more resistant to DT than are the wild-type cells. These investigators proposed that this class of mutants has a block at a step in the intoxication process that is between toxin binding and its pH-dependent entry into the cytosol from an intracellular vesicle (24) .
The observation that the aId retained the toxin on the cell surface-i.e., accessible to cleavage by Pronase-strongly suggests that the cell-surface component affected by aId is involved in an early step (subsequent to toxin binding) in the intoxication process, possibly the movement of the receptor into coated pits or its subsequent internalization from coated pits. Use of anti-idiotypic antibodies should allow the further
